Latest Breaking News On - Global thalassemia - Page 1 : comparemela.com

Global Thalassemia Market Global Thalassemia Market Dublin, Aug. 29, 2023 (GLOBE NEWSWIRE) The "Global Thalassemia Market (2023-2028) by Type, Disease Type, End User, and Geography, Competitive Analysis, Impact of Covid-19 and Ansoff Analysis" report has been added to ResearchAndMarkets.com's offering. The report provides a comprehensive overview and detailed insights into the global thalassemia market. It covers data and analysis related to thalassemia prevalence, treatment methods, market s

South koreaUnited statesUnited kingdomVifor pharmaIncyte corpBellicum pharmaceuticalsTeva pharmaceutical industries ltdErrant gene therapeuticsCalimmune incAcceleron pharma incApopharma incBluebird bio corpGamida cell ltdAlnylam pharmaceuticals incResearch institutesEditas medicine inc